Year: 2026
Type: article
Study design: Case Report
Abstract: Background TFCP2 -rearranged rhabdomyosarcoma ( TFCP2 -RMS) is a rare subtype of fusion-related spindle cell RMS characterized by rearrangement of the TFCP2 gene. In addition to TFCP2 gene rearrangement, researchers have identified multiple molecular aberrations. Case presentation Herein, we report a 53-year-old male patient with TFCP2 -RMS and MDM2 gene amplification. The patient underwent surgery at the initial hospital 5 months ago to remove the right ascending pubic ramus and the right acetabular tumor. Recurrence and metastasis were detected 1 month after surgery. Histologically, the tumor showed a mixture of spindle and epithelioid tumor cells, with immature bone trabeculae and osteoclastic giant cells in the background. Tumor cells were positive for CK, Vimentin, MDM2, CDK4, and ALK, focally positive for MyoD1, and negative for SMA, Desmin, and Myogenin. In addition, TFCP2 gene rearrangement and MDM2 gene amplification were detected, and the case was diagnosed as TFCP2 -RMS with MDM2 gene amplification. Unfortunately, the patient died of the disease 9 months after his initial visit. Conclusion TFCP2 -RMS is a rare, highly aggressive malignant tumor with heterogeneity in molecular aberrations, morphology, and immunophenotype. Molecular testing facilitates accurate diagnosis and early clinical management.
Source: Frontiers in Oncology
Authors: Wenfeng Xu(Writing – original draft, Writing – review & editing), Ying Chen(Conceptualization, Writing – review & editing), Hao Tang(Conceptualization, Writing – review & editing), Caijun Huang(Writing – original draft), Qijian Ying(Methodology, Writing – original draft), Zhongjiao Chen(Methodology, Writing – original draft), Deyu Guo(Conceptualization, Writing – review & editing)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7234180259
